Guselkumab Improves Abdominal Pain and Bowel Urgency Symptoms in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study

被引：0

作者：

Rubin, David T. ^{[1
]}

Panes, Julian ^{[2
]}

Feagan, Brian G. ^{[3
]}

Yarandi, Shadi ^{[4
]}

Huang, Kuan-Hsiang G. ^{[4
]}

Germinaro, Matthew ^{[4
]}

Han, Chenglong ^{[5
]}

Miao, Ye ^{[4
]}

Zhang, Hongyan ^{[4
]}

Qiu, Yun ^{[6
]}

Klopocka, Maria ^{[7
]}

Duvall, George ^{[8
]}

Lichtenstein, Gary R. ^{[9
]}

Hisamatsu, Tadakazu ^{[10
]}

Bressler, Brian ^{[11
]}

Peyrin-Biroulet, Laurent ^{[12
,13
]}

机构：

[1] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA

[2] Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Catalonia, Spain

[3] Western Univ, London, ON, Canada

[4] Janssen Res & Dev LLC, Spring House, PA USA

[5] Janssen Global Serv LLC, Malvern, PA USA

[6] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[7] Szpital Uniwersytecki 2 Dr Jana Biziela Bydgoszcz, Bydgoszcz, Pomorskie, Poland

[8] Tyler Res Inst LLC, Tyler, TX USA

[9] Univ Penn, Philadelphia, PA USA

[10] Kyorin Univ, Sch Med, Tokyo, Japan

[11] St Pauls Hosp, Vancouver, BC, Canada

[12] Lorraine Univ, Last Inserm U954, Vandoeuvre Les Nancy, Lorraine, France

[13] Lorraine Univ, CHU Nancy, Vandoeuvre Les Nancy, Lorraine, France

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S907

引用

页码：S677 / S677

页数：1

共 50 条

[1] Guselkumab improves abdominal pain and bowel urgency symptoms in patients with moderately to severely active ulcerative colitis: Results from the phase 3 QUASAR induction study
Rubin, D.
Panes, J.
Feagan, B.
Yarandi, S.
Huang, K. H.
Germinaro, M.
Han, C.
Miao, Y.
Zhang, H.
Qiu, Y.
Klopocka, M.
Duvall, G.
Lichtenstein, G.
Hisamatsu, T.
Bressler, B.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1816 - I1817
[2] GUSELKUMAB IMPROVES SYMPTOMS OF FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY RESULTS AT WEEK 12
Dignass, Axel
Panes, Julian
Rubin, David T.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Pandya, Dwiti
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Gu, Fang
Rowbotham, David S.
Mihaly, Emese
Bressler, Brian
Lichtenstein, Gary R.
Allegretti, Jessica R.
GASTROENTEROLOGY, 2024, 166 (05) : S848 - S849
[3] Guselkumab improves symptoms of fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study results at Week 12
Dignass, A.
Panes, J.
Rubin, D. T.
Huang, K. H. G.
Germinaro, M.
Pandya, D.
Han, C.
Miao, Y.
Zhang, H.
Gu, F.
Rowbotham, D.
Mihaly, E.
Bressler, B.
Lichtenstein, G. R.
Allegretti, J. R.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I165 - I166
[4] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
Allegretti, Jessica R.
Peyrin-Biroulet, Laurent
Feagan, Brian G.
Bressler, Brian
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Shipitofsky, Nicole
Jiang, Lingjing
Zhang, Hongyan
Hisamatsu, Tadakazu
Panes, Julian
Dignass, Axel
Sands, Bruce E.
Rubin, David T.
GASTROENTEROLOGY, 2023, 164 (06) : S1572 - S1572
[5] Guselkumab Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the QUASAR Phase 3 Induction Study
Bressler, Brian
Feagan, Brian G.
Panes, Julian
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Pandya, Dwiti
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Lateef, Syed
Petroniene, Rima
Rayyan, Yaser
Peyrin-Biroulet, Laurent
Rubin, David T.
Hisamatsu, Tadakazu
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S807 - S808
[6] Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study
Lichtenstein, Gary R.
Dignass, Axel
Rubin, David T.
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Miao, Ye
Zhang, Hongyan
Kierkus, Jaroslaw
Seidler, Ursula
Maemoto, Atsuo
Allegretti, Jessica R.
Bressler, Brian
Peyrin-Biroulet, Laurent
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S623 - S624
[7] Guselkumab induction therapy results in molecular resolution of inflammation in moderately to severely active Ulcerative Colitis: results from the Phase 3 QUASAR induction study
Sridhar, S.
Hart, A.
Venkat, S.
Huang, K. H. G.
Yarandi, S.
Germinaro, M.
Vetter, M.
Rubin, D. T.
Dignass, A.
Cua, D.
Freeman, T.
Waterworth, D.
Mcrae, B.
Verstockt, B.
Branigan, P.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i422 - i422
[8] Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
Peyrin-Biroulet, Laurent
Allegretti, Jessica R.
Rubin, David T.
Bressler, Brian
Germinaro, Matthew
Huang, Kuan-Hsiang
Shipitofsky, Nicole
Zhang, Hongyan
Wilson, Rebbecca
Han, Chenglong
Feagan, Brian G.
Sandborn, William J.
Panes, Julian
Hisamatsu, Tadakazu
Lichtenstein, Gary R.
Sands, Bruce E.
Dignass, Axel
GASTROENTEROLOGY, 2023, 165 (06) : 1443 - 1457
[9] Cumulative response to guselkumab through week 24 of induction in patients with moderately to severely active ulcerative colitis: Results from the phase 3 QUASAR induction study
Rubin, D.
Sands, B.
Lichtenstein, G.
Baker, T.
Huang, K. H.
Germinaro, M.
Miao, Y.
Zhang, H.
Nancey, S.
Allegretti, J.
Feagan, B.
Hisamatsu, T.
Panes, J.
Dignass, A.
Bressler, B.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1722 - I1723
[10] Cumulative Response to Guselkumab Through Week 24 of Induction in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study
Rubin, David T.
Sands, Bruce E.
Lichtenstein, Gary R.
Baker, Thomas
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Miao, Ye
Zhang, Hongyan
Nancey, Stephane
Allegretti, Jessica R.
Feagan, Brian G.
Hisamatsu, Tadakazu
Panes, Julian
Dignass, Axel
Bressler, Brian
Peyrin-Biroulet, Laurent
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S672 - S673

← 1 2 3 4 5 →